Skip to main navigation Skip to search Skip to main content

Nichtmuskelinvasives Urothelkarzinom: Ist die Anwendung von BCG noch notwendig?

Translated title of the contribution: Non-muscle-invasive transitional cell carcinoma. Is BCG still a necessary part of treatment?

F. Vom Dorp*, S. Tschirdewahn, H. Rübben, D. Jocham

*Corresponding author for this work
1   Link opens in a new tab Citation (Scopus)

Fingerprint

Dive into the research topics of 'Non-muscle-invasive transitional cell carcinoma. Is BCG still a necessary part of treatment?'. Together they form a unique fingerprint.
Sort by

Nursing and Health Professions

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science